Literature DB >> 16170471

The response to sex steroid hormones and vitamin D of cultured osteoblasts derived from ovariectomized mice with and without 17beta-estradiol pretreatment.

Natan Patlas1, Yehuda Zadik, Pirhya Yaffe, Michael Patlas, Zvi Schwartz, Asher Ornoy.   

Abstract

This study investigated whether 17beta-estradiol (E2) may have different effects on osteoblasts derived from estrogen-deficient ovariectomized (OVX) mice compared to sham-operated normal animals. We studied the specific effects of 17beta-estradiol on the differentiation and function of cultured osteoblasts derived from these groups of animals, with or without estrogen replacement treatment. One-month-old mice were ovariectomized or sham-operated, and treated (every second day) for 4 weeks with 0.5 mg/kg 17beta-estradiol or with vehicle alone. At the end of the experiment, bones were removed for primary osteoblast cultures or for morphological and chemical evaluation. In cells from untreated OVX animals, alkaline phosphatase (ALP) specific activity was reduced, while collagen production and mineralization were unchanged when compared to cells from controls. In vivo estrogen pretreatment of the OVX mice elevated ALP activity and mineralization of the cells, while collagen production was reduced. The addition of 17beta-estradiol to the culture medium increased ALP activity, collagen production, and mineralization by all cultured osteoblasts, except in those derived from sham-operated, estrogen-pretreated mice, where these features remained unchanged. Osteocalcin production was unchanged. Addition of testosterone or 1,25(OH)2D3 to the culture medium induced changes that differed among the groups depending on the source of the cultured cells. It seems that ovariectomy in mice prior to culture affected the phenotype of the cultured osteoblasts and their response to estradiol, testosterone, and 1,25(OH)2D3, depending on whether animals were pretreated with estradiol or not. These results imply that the animal's estrogen status prior to culture can influence the response to estrogens; this finding may have important implications for hormone replacement therapy (HRT) in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170471     DOI: 10.1007/s10266-005-0051-z

Source DB:  PubMed          Journal:  Odontology        ISSN: 1618-1247            Impact factor:   2.634


  31 in total

1.  Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta.

Authors:  Ryo Okazaki; Daisuke Inoue; Minako Shibata; Mieko Saika; Shinsuke Kido; Hikari Ooka; Hirofumi Tomiyama; Yoshikazu Sakamoto; Toshio Matsumoto
Journal:  Endocrinology       Date:  2002-06       Impact factor: 4.736

2.  Isolation and hormonal responsiveness of primary cultures of human bone-derived cells: gender and age differences.

Authors:  S Katzburg; M Lieberherr; A Ornoy; B Y Klein; D Hendel; D Somjen
Journal:  Bone       Date:  1999-12       Impact factor: 4.398

3.  Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells.

Authors:  P E Keeting; R E Scott; D S Colvard; I K Han; T C Spelsberg; B L Riggs
Journal:  J Bone Miner Res       Date:  1991-03       Impact factor: 6.741

Review 4.  The pathophysiology and treatment of postmenopausal osteoporosis. An evidence-based approach to estrogen replacement therapy.

Authors:  C J Rosen; C R Kessenich
Journal:  Endocrinol Metab Clin North Am       Date:  1997-06       Impact factor: 4.741

5.  Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins.

Authors:  B Peterkofsky; R Diegelmann
Journal:  Biochemistry       Date:  1971-03-16       Impact factor: 3.162

6.  Effect of estrogen and 1alpha,25(OH)2- vitamin D3 on the activity and growth of human primary osteoblast-like cells in vitro.

Authors:  Fang-Ping Chen; Ning Lee; Kun-Chuang Wang; Yung-Kui Soong; Ko-En Huang
Journal:  Fertil Steril       Date:  2002-05       Impact factor: 7.329

7.  Human skeletal alkaline phosphatase. Kinetic studies including pH dependence and inhibition by theophylline.

Authors:  J R Farley; J L Ivey; D J Baylink
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

8.  Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice.

Authors:  S Zhou; Y Zilberman; K Wassermann; S D Bain; Y Sadovsky; D Gazit
Journal:  J Cell Biochem Suppl       Date:  2001

9.  Age-dependent expression of osteoblastic phenotypic markers in normal human osteoblasts cultured long-term in the presence of dexamethasone.

Authors:  M S Sutherland; L G Rao; S A Muzaffar; J N Wylie; M M Wong; R J McBroom; T M Murray
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

10.  Estrogen added intermittently, but not continuously, stimulates differentiation and bone formation in SaOS-2 cells.

Authors:  Leticia Gomez Rao; Lily Jin-Fang Liu; Timothy McCleod Murray; Elizabeth McDermott; Xizhong Zhang
Journal:  Biol Pharm Bull       Date:  2003-07       Impact factor: 2.233

View more
  4 in total

1.  Decreased response of osteoblasts obtained from aged Cohen diabetic sensitive rats to sex steroid hormones and 1,25OH2D3 in culture.

Authors:  Asher Ornoy; Perchia Yaffe; Sarah W Zangen; Nathan Patlas; Zvi Schwartz
Journal:  Odontology       Date:  2006-09       Impact factor: 2.634

2.  Signaling pathways implicated in androgen regulation of endocortical bone.

Authors:  Kristine M Wiren; Anthony A Semirale; Joel G Hashimoto; Xiao-Wei Zhang
Journal:  Bone       Date:  2009-11-04       Impact factor: 4.398

3.  Estrogen inhibits starvation-induced apoptosis in osteocytes by a redox-independent process involving association of JNK and glutathione S-transferase P1-1.

Authors:  Vladana Domazetovic; Filippo Fontani; Gemma Marcucci; Teresa Iantomasi; Maria Luisa Brandi; Maria Teresa Vincenzini
Journal:  FEBS Open Bio       Date:  2017-04-05       Impact factor: 2.693

4.  Comparison of the Anabolic Effects of Reported Osteogenic Compounds on Human Mesenchymal Progenitor-derived Osteoblasts.

Authors:  Robert Owen; Hossein Bahmaee; Frederik Claeyssens; Gwendolen C Reilly
Journal:  Bioengineering (Basel)       Date:  2020-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.